Patent Power Portfolio
Invest in the companies that own the blueprints to our digital future. These carefully selected firms hold valuable patents for virtual and augmented reality technology, positioning them at the foundation of the emerging metaverse economy.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Meta Platforms Inc (Facebook)
META
Current price
$751.48
Heavily invests in the metaverse through its Reality Labs division, developing foundational hardware like the Meta Quest headset and holding a vast IP...
Heavily invests in the metaverse through its Reality Labs division, developing foundational hardware like the Meta Quest headset and holding a vast IP portfolio.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
About This Group of Stocks
Our Expert Thinking
This collection focuses on companies with strategic advantage through intellectual property ownership. Rather than betting on single consumer applications, we've identified firms with patents for the core technologies that will power the entire metaverse ecosystem, from hardware to software.
What You Need to Know
This is a high-growth, technology-forward allocation suitable for diversified portfolios. These companies are seeing accelerating adoption as AR/VR technology moves beyond gaming into enterprise, industrial, and medical applications, unlocking new revenue streams.
Why These Stocks
Each company was selected for its significant and defensible patent portfolio in crucial areas of AR/VR development. These firms supply essential technology needed to build and experience immersive virtual spaces, from headsets and haptic feedback to powerful rendering engines.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+29.95%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 29.95% over the next year.
Stocks Rated Buy by Analysts
15 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Owning the Digital Blueprint
These companies hold the patents to technologies everyone else must license or work around. As metaverse adoption grows, so does the value of their intellectual property.
Beyond Gaming into Enterprise
The transition of AR/VR from entertainment into training, healthcare, and manufacturing is creating massive new revenue opportunities that many investors haven't fully recognized yet.
Protected Innovation Moats
Patent portfolios create defensible business positions that can generate licensing revenue for years to come, even as the technology landscape evolves.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
The New Cost of Compliance: Investing in HR Tech
Australian airline Qantas received a historic $58 million fine for unlawfully dismissing workers, setting a new precedent for corporate accountability in labor practices. This ruling creates an investment opportunity in companies that provide the essential HR, legal, and compliance technologies businesses now need to navigate stricter labor law enforcement.
GLP-1s Target Liver Disease
The FDA's approval of Wegovy for a serious liver disease has boosted Novo Nordisk's market position and highlighted a major new application for GLP-1 drugs. This development creates an investment opportunity in companies focused on innovative treatments for metabolic and liver-related conditions.
Pharma's Digital Prescription
Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.
Frequently Asked Questions
Everything you need to know about the product and billing.